Cargando…

Beneficial Effects of the Activation of the Angiotensin-(1–7) Mas Receptor in a Murine Model of Adriamycin-Induced Nephropathy

Angiotensin-(1–7) [Ang-(1–7)] is a biologically active heptapeptide that may counterbalance the physiological actions of angiotensin II (Ang II) within the renin-angiotensin system (RAS). Here, we evaluated whether activation of the Mas receptor with the oral agonist, AVE 0991, would have renoprotec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silveira, Kátia Daniela, Barroso, Lívia Corrêa, Vieira, Angélica Thomáz, Cisalpino, Daniel, Lima, Cristiano Xavier, Bader, Michael, Arantes, Rosa Maria Esteves, dos Santos, Robson Augusto Souza, Simões-e-Silva, Ana Cristina, Teixeira, Mauro Martins
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676359/ https://www.ncbi.nlm.nih.gov/pubmed/23762470 http://dx.doi.org/10.1371/journal.pone.0066082

Ejemplares similares

Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury
por: Barroso, Lívia Corrêa, et al.
Publicado: (2012)

Dual deficiency of angiotensin‐converting enzyme‐2 and Mas receptor enhances angiotensin II‐induced hypertension and hypertensive nephropathy
por: Ni, Jun, et al.
Publicado: (2020)

Effects of Pravastatin in Adriamycin-Induced Nephropathy in Rats
por: Mansouri, Esrafil, et al.
Publicado: (2018)

Angiotensin-(1-7) and Mas: A Brief History
por: Alenina, Natalia, et al.
Publicado: (2015)

Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2012)

Simvastatin ameliorates glomerulosclerosis in Adriamycin-induced-nephropathy rats
por: Zhang, Wei, et al.
Publicado: (2008)

Angiotensin-(1-7)/Angiotensin-Converting Enzyme 2/Mas Receptor Axis and Related Mechanisms
por: Ferreira, Anderson J., et al.
Publicado: (2012)

Endothelin Receptor A Blockade Is an Ineffective Treatment for Adriamycin Nephropathy
por: Tan, Roderick J., et al.
Publicado: (2013)

Angiotensin-(1-7) Prevents Lipopolysaccharide-Induced Autophagy via the Mas Receptor in Skeletal Muscle
por: Rivera, Juan Carlos, et al.
Publicado: (2020)

Beneficial Effect of Mas Receptor Deficiency on Vascular Cognitive Impairment in the Presence of Angiotensin II Type 2 Receptor
por: Higaki, Akinori, et al.
Publicado: (2018)

Angiotensin II type 1 receptor blockers favorably affect renal angiotensin II and MAS receptor expression in patients with diabetic nephropathy
por: Ma, Ye-Ping, et al.
Publicado: (2020)

The Cooperative Effect of Local Angiotensin-II in Liver with Adriamycin Hepatotoxicity on Mitochondria
por: Taskin, Eylem, et al.
Publicado: (2016)

Vincristine alleviates adriamycin-induced nephropathy through stabilizing actin cytoskeleton
por: Yin, Lei, et al.
Publicado: (2017)

Ameliorating Effect of Gemigliptin on Renal Injury in Murine Adriamycin-Induced Nephropathy
por: Kim, Da Rae, et al.
Publicado: (2017)

Salidroside ameliorates Adriamycin nephropathy in mice by inhibiting β‐catenin activity
por: Huang, Xinzhong, et al.
Publicado: (2019)

Mesenchymal Stem Cells Ameliorate Renal Inflammation in Adriamycin-induced Nephropathy
por: Kim, Hyung Sook, et al.
Publicado: (2019)

Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas
por: Morales, María Gabriela, et al.
Publicado: (2016)

Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis
por: Takiue, Keiichi, et al.
Publicado: (2012)

Glomerular Endothelial Cell Injury and Damage Precedes That of Podocytes in Adriamycin-Induced Nephropathy
por: Sun, Yu Bo Yang, et al.
Publicado: (2013)

Cobrotoxin from Naja naja atra Venom Ameliorates Adriamycin Nephropathy in Rats
por: Wang, Shu-Zhi, et al.
Publicado: (2015)

Paricalcitol Improves the Angiopoietin/Tie-2 and VEGF/VEGFR2 Signaling Pathways in Adriamycin-Induced Nephropathy
por: Deluque, Amanda Lima, et al.
Publicado: (2022)

Angiotensin (1-7)/Mas receptor axis activation ameliorates the changes in fatty acid composition in diabetic rats with nephropathy
por: Singh, Kulwinder, et al.
Publicado: (2010)

Erratum to “Effect of Nephropathy Prescription I on the Expression of Angptl3 and Podocyte-Associated Protein in Mice with Adriamycin-Induced Nephropathy”
por: Zhang, Feifei, et al.
Publicado: (2023)

Treatment with irbesatan may improve slit diaphragm alterations in rats with adriamycin-induced nephropathy
por: Wang, Na, et al.
Publicado: (2016)

Effects of a Chinese herbal extract on the intestinal tract and aquaporin in Adriamycin-induced nephropathy
por: Ma, Weizhong, et al.
Publicado: (2022)

Genetic background strongly influences the transition to chronic kidney disease of adriamycin nephropathy in mice
por: Watanabe, Masaki, et al.
Publicado: (2022)

New Cardiovascular and Pulmonary Therapeutic Strategies Based on the Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas Receptor Axis
por: Ferreira, Anderson J., et al.
Publicado: (2012)

Gonadotropin Stimulation Increases the Expression of Angiotensin-(1–7) and Mas Receptor in the Rat Ovary
por: Pereira, Virgínia M., et al.
Publicado: (2009)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Impact of Light/Dark Cycle Patterns on Oxidative Stress in an Adriamycin-Induced Nephropathy Model in Rats
por: Escribano, Begoña M., et al.
Publicado: (2014)

Osteocrin ameliorates adriamycin nephropathy via p38 mitogen-activated protein kinase inhibition
por: Handa, Takaya, et al.
Publicado: (2021)

Adriamycin-Induced Nephropathy is Robust in N and Modest in J Substrain of C57BL/6
por: Bryant, Claire, et al.
Publicado: (2022)

Capsazepine (CPZ) Inhibits TRPC6 Conductance and Is Protective in Adriamycin-Induced Nephropathy and Diabetic Glomerulopathy
por: Hagmann, Henning, et al.
Publicado: (2023)

Mas-Mediated Antioxidant Effects Restore the Functionality of Angiotensin Converting Enzyme 2-Angiotensin-(1–7)-Mas Axis in Diabetic Rat Carotid
por: Pernomian, Larissa, et al.
Publicado: (2014)

Angiotensin-(1-7)/MasR axis promotes migration of monocytes/macrophages with a regulatory phenotype to perform phagocytosis and efferocytosis
por: Zaidan, Isabella, et al.
Publicado: (2022)

Correction: Impact of Light/Dark Cycle Patterns on Oxidative Stress in an Adriamycin-Induced Nephropathy Model in Rats
Publicado: (2014)

Human induced pluripotent stem cell-derived mesenchymal stem cells prevent adriamycin nephropathy in mice
por: Wu, Hao Jia, et al.
Publicado: (2017)

Histological study on the protective effect of endogenous stem-cell mobilization in Adriamycin-induced chronic nephropathy in rats
por: Sadek, Eman Mostafa, et al.
Publicado: (2016)

Inflammation Induces Lipid Deposition in Kidneys by Downregulating Renal PCSK9 in Mice with Adriamycin-Induced Nephropathy
por: Zhang, Gaofu, et al.
Publicado: (2019)

Yes-associated protein regulates podocyte cell cycle re-entry and dedifferentiation in adriamycin-induced nephropathy
por: Xie, Kewei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1lohkte4t5bm98smm5je3rf708